Austin, TX – According to filings with the U.S. Securities and Exchange Commission, MicroTransponder is raising $6,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Operating Officer, Jordan Curnes played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About MicroTransponder

MicroTransponder has developed therapies to treat several neurological conditions. Headquartered in Texas, MicroTransponder Inc. (MTI) has developed the Paired Vagus Nerve Stimulation System (Paired VNS System) based on decades of neuroscience research. The Paired VNS System has been developed to treat two separate neurological conditions. The first is the Serenity System for the treatment of chronic tinnitus. The second is the Vivistim System for treatment of post-stroke upper limb mobility issues.

To learn more about MicroTransponder, visit http://www.microtransponder.com/

Contact:
Jordan Curnes, President and Chief Operating Officer
214-280-9677
jordan@microtransponder.com
https://www.linkedin.com/in/jordancurnes/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved